199 related articles for article (PubMed ID: 33930802)
1. Design, synthesis of novel celastrol derivatives and study on their antitumor growth through HIF-1α pathway.
Shang FF; Wang JY; Xu Q; Deng H; Guo HY; Jin X; Li X; Shen QK; Quan ZS
Eur J Med Chem; 2021 Aug; 220():113474. PubMed ID: 33930802
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and evaluation of 3-(phenylethynyl)-1,1'-biphenyl-2-carboxylate derivatives as new HIF-1 inhibitors.
Wang S; Wang X; Shao Y; Shao K; Wang Y; Guo X; Dong H; Zhao W; Li Y; Li G
Bioorg Chem; 2021 Nov; 116():105298. PubMed ID: 34454298
[TBL] [Abstract][Full Text] [Related]
3. Celastrol inhibits the HIF-1α pathway by inhibition of mTOR/p70S6K/eIF4E and ERK1/2 phosphorylation in human hepatoma cells.
Ma J; Han LZ; Liang H; Mi C; Shi H; Lee JJ; Jin X
Oncol Rep; 2014 Jul; 32(1):235-42. PubMed ID: 24859482
[TBL] [Abstract][Full Text] [Related]
4. Inhibitory action of Celastrol on hypoxia-mediated angiogenesis and metastasis via the HIF-1α pathway.
Huang L; Zhang Z; Zhang S; Ren J; Zhang R; Zeng H; Li Q; Wu G
Int J Mol Med; 2011 Mar; 27(3):407-15. PubMed ID: 21249310
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and biological evaluation of celastrol derivatives as potent antitumor agents with STAT3 inhibition.
Xu S; Fan R; Wang L; He W; Ge H; Chen H; Xu W; Zhang J; Xu W; Feng Y; Fan Z
J Enzyme Inhib Med Chem; 2022 Dec; 37(1):236-251. PubMed ID: 34894961
[TBL] [Abstract][Full Text] [Related]
6. Dictamnine promotes apoptosis and inhibits epithelial-mesenchymal transition, migration, invasion and proliferation by downregulating the HIF-1α and Slug signaling pathways.
Wang JY; Wang Z; Li MY; Zhang Z; Mi C; Zuo HX; Xing Y; Wu YL; Lian LH; Xu GH; Piao LX; Ma J; Jin X
Chem Biol Interact; 2018 Dec; 296():134-144. PubMed ID: 30266538
[TBL] [Abstract][Full Text] [Related]
7. Design, synthesis, and evaluation of benzofuran derivatives as novel anti-pancreatic carcinoma agents via interfering the hypoxia environment by targeting HIF-1α pathway.
Xu XL; Yang YR; Mo XF; Wei JL; Zhang XJ; You QD
Eur J Med Chem; 2017 Sep; 137():45-62. PubMed ID: 28554092
[TBL] [Abstract][Full Text] [Related]
8. Discovery of derivatives of 6(7)-amino-3-phenylquinoxaline-2-carbonitrile 1,4-dioxides: novel, hypoxia-selective HIF-1α inhibitors with strong antiestrogenic potency.
Buravchenko GI; Scherbakov AM; Dezhenkova LG; Bykov EE; Solovieva SE; Korlukov AA; Sorokin DV; Monzote Fidalgo L; Shchekotikhin AE
Bioorg Chem; 2020 Nov; 104():104324. PubMed ID: 33142432
[TBL] [Abstract][Full Text] [Related]
9. Design, synthesis, and evaluation of novel ursolic acid derivatives as HIF-1α inhibitors with anticancer potential.
Chi KQ; Wei ZY; Wang KS; Wu J; Chen WQ; Jin XJ; Piao HR
Bioorg Chem; 2017 Dec; 75():157-169. PubMed ID: 28950243
[TBL] [Abstract][Full Text] [Related]
10. Celastrol Inhibits the Proliferation and Decreases Drug Resistance of Cisplatin- Resistant Gastric Cancer SGC7901/DDP Cells.
Zhan D; Ni T; Wang H; Lv M; Sunagawa M; Liu Y
Anticancer Agents Med Chem; 2022; 22(2):270-279. PubMed ID: 34053427
[TBL] [Abstract][Full Text] [Related]
11. Design, synthesis, and target identification of new hypoxia-inducible factor 1 (HIF-1) inhibitors containing 1-alkyl-1H-pyrazole-3-carboxamide moiety.
Sakai M; Takahashi N; Ikeda H; Furutani Y; Higuchi S; Suzuki T; Dohmae N; Kobayashi S; Harada H; Kojima S; Matsuura T; Hattori A; Kakeya H
Bioorg Med Chem; 2021 Sep; 46():116375. PubMed ID: 34492592
[TBL] [Abstract][Full Text] [Related]
12. Design, synthesis, and screening of novel ursolic acid derivatives as potential anti-cancer agents that target the HIF-1α pathway.
Wu J; Zhang ZH; Zhang LH; Jin XJ; Ma J; Piao HR
Bioorg Med Chem Lett; 2019 Mar; 29(6):853-858. PubMed ID: 30728113
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and biological evaluation of celastrol derivatives as potential anti-glioma agents by activating RIP1/RIP3/MLKL pathway to induce necroptosis.
Feng Y; Wang W; Zhang Y; Fu X; Ping K; Zhao J; Lei Y; Mou Y; Wang S
Eur J Med Chem; 2022 Feb; 229():114070. PubMed ID: 34968902
[TBL] [Abstract][Full Text] [Related]
14. Design, synthesis and biological evaluation of novel C-29 carbamate celastrol derivatives as potent and selective cytotoxic compounds.
Figueiredo SAC; Salvador JAR; Cortés R; Cascante M
Eur J Med Chem; 2017 Oct; 139():836-848. PubMed ID: 28865279
[TBL] [Abstract][Full Text] [Related]
15. Celastrol stimulates hypoxia-inducible factor-1 activity in tumor cells by initiating the ROS/Akt/p70S6K signaling pathway and enhancing hypoxia-inducible factor-1α protein synthesis.
Han X; Sun S; Zhao M; Cheng X; Chen G; Lin S; Guan Y; Yu X
PLoS One; 2014; 9(11):e112470. PubMed ID: 25383959
[TBL] [Abstract][Full Text] [Related]
16. Design, synthesis, and biofunctional evaluation of novel pentacyclic triterpenes bearing O-[4-(1-piperazinyl)-4-oxo-butyryl moiety as antiproliferative agents.
Zhao CH; Zhang CL; Shi JJ; Hou XY; Feng B; Zhao LX
Bioorg Med Chem Lett; 2015 Oct; 25(20):4500-4. PubMed ID: 26343825
[TBL] [Abstract][Full Text] [Related]
17. Ring-truncated deguelin derivatives as potent Hypoxia Inducible Factor-1α (HIF-1α) inhibitors.
Kim HS; Hong M; Lee SC; Lee HY; Suh YG; Oh DC; Seo JH; Choi H; Kim JY; Kim KW; Kim JH; Kim J; Kim YM; Park SJ; Park HJ; Lee J
Eur J Med Chem; 2015 Nov; 104():157-64. PubMed ID: 26457742
[TBL] [Abstract][Full Text] [Related]
18. Novel chalcone derivatives as hypoxia-inducible factor (HIF)-1 inhibitor: synthesis, anti-invasive and anti-angiogenic properties.
Wang L; Chen G; Lu X; Wang S; Han S; Li Y; Ping G; Jiang X; Li H; Yang J; Wu C
Eur J Med Chem; 2015 Jan; 89():88-97. PubMed ID: 25462229
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and evaluation of HIF-1α inhibitory activities of novel panaxadiol derivatives.
Wang DY; Li YW; Zhang LH; Lv LY; Zhao YQ; Jin XJ; Piao HR
Bioorg Med Chem Lett; 2020 Dec; 30(24):127652. PubMed ID: 33130293
[TBL] [Abstract][Full Text] [Related]
20. Synthesis, computational docking and biological evaluation of celastrol derivatives as dual inhibitors of SERCA and P-glycoprotein in cancer therapy.
Coghi P; Ng JPL; Kadioglu O; Law BYK; Qiu AC; Saeed MEM; Chen X; Ip CK; Efferth T; Liu L; Wong VKW
Eur J Med Chem; 2021 Nov; 224():113676. PubMed ID: 34256125
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
